About: http://webisa.webdatacommons.org/147262313

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The acquisition was a strategic addition to Bard??s portfolio of non-coronary stent and stent graft products that is complementary to the company??s current products, call points and technology platforms.
http://www.w3.org/ns/prov#wasQuotedFrom	marketplace.org